Home » Topics » BioWorld Science

BioWorld Science
RSS

p65 antisense oligonucleotides for Crohn's disease

Sep. 27, 1996

Generic dicyclomine HCl now available in the U.S.

Sep. 27, 1996

Yamanouchi reports agent for urinary incontinence

Sep. 27, 1996

Gensia and Microbix agreement for generic urokinase alternative

Sep. 27, 1996

Tanabe reports t-PA-enhancing compounds

Sep. 27, 1996

gpIIb/IIIa antagonist selected for clinical evaluation at DuPont Merck

Sep. 27, 1996

DuPont Merck proposes new standards for warfarin products

Sep. 27, 1996

Thrombin inhibitors with improved selectivity from Servier

Sep. 27, 1996

Cardiovascular R&D at Takeda

Sep. 27, 1996

New treatment for peripheral vascular diseases cleared for clinical trials in the U.K.

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026